Doozio Posted - 16 hours ago

$PCVX or a 🐑 term correction which creates a $$ pattern retest 🎁 in 🧠⏰♾️

insiderbuyingselling Posted - 04/25/24

$PCVX new insider selling: 15000 shares. http://insiderbuyingselling.com/?t=PCVX

insiderbuyingselling Posted - 04/23/24

$PCVX new insider selling: 8000 shares. http://insiderbuyingselling.com/?t=PCVX

Nosh Posted - 04/15/24

$PCVX Started a position here today...like the chart.

Night_Owl_Biotech Posted - 04/14/24

We track the share prices of 12 biopharmas that are primarily focused on vaccine therapies. The attachment notes the share prices of the subject 12 since year end. We are only aware of Iscovax that was recently acquired. 11 of the 12 are trading lower year to date. Please let us know if we are missing any biopharmas primarily, again primarily, focused on developing vaccine therapies. We are aware of those with vaccines in their portfolio like AGEN. As always, our data could be wrong. Thank you. $HLVX $PCVX $DVAX $ARCT $NVAX

Thestocktraderhubzee Posted - 04/10/24

$PCVX Needham Reiterates Buy on Vaxcyte, Maintains $95 Price Target

RonIsWrong Posted - 04/07/24

$PHAT $RYTM $PCVX Phathom Pharmaceuticals ($PHAT), Rhythm Pharmaceuticals ($RYTM), and Vaxcyte ($PCVX) are the most likely takeout targets in the pharma space, according to a Needham analyst. The three companies are the most likely to be acquired in Needham's coverage universe, Needham analyst Joseph Stringer wrote in a note on Friday. Needham has a buy rating and $26 price target on Phathom (PHAT), a buy rating and $95 price target on Vaxcyte (PCVX) and a $50 price target and buy rating on Rhythm (RYTM).

OpenOutcrier Posted - 04/05/24

RECAP 4/5 +Pos Comments: $PCVX + Needham $PHAT + Needham $RYTM + Needham RECAP 4/5 -Neg Comments: $PEGY - Northland $ATUS - WFC Live Breaking trading news www.openoutcrier.com

Quantumup Posted - 04/05/24

Needham believes $RYTM $PHAT $PCVX likely to be acquired: Notes M&A's are well above the 8.2 qtrly avg since '18. Thinks M&A will remain above avg for the remainder of '24 and skew more toward mid-stage target cos w/ deal sizes in the $1-3B range and w/ more focus on Oncology/Immunology/Rare Disease. SNY MRK LLY PFE NVS RHHBY REGN TAK BIIB BMY BAYRY

Stock_Titan Posted - 4 weeks ago

$PCVX Vaxcyte to Present at the 23rd Annual Needham Virtual Healthcare Conference https://www.stocktitan.net/news/PCVX/vaxcyte-to-present-at-the-23rd-annual-needham-virtual-healthcare-ls4ewg7pxnkk.html

StockInvest_us Posted - 1 month ago

Signal alert: $PCVX - Oversold Trend Short (Undervalued) https://stockinvest.us/l/iRoUk1CTsg

StockInvest_us Posted - 03/30/24

Signal alert: $PCVX - Oversold Trend Short (Undervalued) https://stockinvest.us/l/OOjAGEehpn

insiderbuyingselling Posted - 03/27/24

$PCVX new insider selling: 15000 shares. http://insiderbuyingselling.com/?t=PCVX

StockInvest_us Posted - 03/27/24

Signal alert: $PCVX - Oversold Trend Short (Undervalued) https://stockinvest.us/l/iJMxFq1T91

G101SPM Posted - 03/05/24

@S_Franconi per request: $PCVX $71.69 carries SPM 83.01 tag as neutral (confirmed by 12.5% short against true float). --- Next major event Phase 2 study evaluating VAX-24, a broad-spectrum, carrier-sparing 24-valent pneumococcal conjugate vaccine candidate designed to prevent invasive pneumococcal disease, in healthy infants. Vaxcyte expects to announce topline safety, tolerability and immunogenicity data from the Phase 2 study primary three-dose immunization series by the end of the first quarter of 2025, followed by topline data from the booster dose by the end of 2025.

S_Franconi Posted - 03/05/24

$PCVX @G101SPM Can you run this one G?

insiderbuyingselling Posted - 03/05/24

$PCVX new insider selling: 3000 shares. http://insiderbuyingselling.com/?t=PCVX

insiderbuyingselling Posted - 03/04/24

$PCVX new insider selling: 2616 shares. http://insiderbuyingselling.com/?t=PCVX

Stock_Titan Posted - 03/04/24

$PCVX Vaxcyte Completes Enrollment of Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease (IPD) in Infants https://www.stocktitan.net/news/PCVX/vaxcyte-completes-enrollment-of-phase-2-study-evaluating-vax-24-for-w9pfoy3lvnyl.html

greensmell Posted - 2 months ago

$PCVX this either goes up really hard or falls down like a stone.

greensmell Posted - 2 months ago

$PCVX truly unacceptable. should be $100+

greensmell Posted - 02/29/24

$PCVX Why are we down today too?

greensmell Posted - 02/28/24

$PCVX garbage

fda_tracker Posted - 02/28/24

$PCVX New PDUFA Date 2024-06-17 Vaxcyte, Inc. Link:https://www.sec.gov/Archives/edgar/data/0001649094/000095017024021145/pcvx-20231231.htm Calendar:http://www.fdatracker.com/fda-calendar/

epsguid Posted - 02/27/24

$PCVX reported a loss of $1.82, consensus was ($0.90) via @eWhispers #epsmiss http://eps.sh/d/pcvx

Stock_Titan Posted - 02/27/24

$PCVX Vaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update https://www.stocktitan.net/news/PCVX/vaxcyte-reports-fourth-quarter-and-full-year-2023-financial-results-mbcf9m0d3wcl.html

SmartestMoney Posted - 02/26/24

$PCVX 60

Doozio Posted - 02/24/24

$PCVX bullish engulfer out da tightness. Only a faatch 💣 stops 💯 or moar in 🧠⏰♾️

S_Franconi Posted - 02/18/24

$PCVX I like this.

Doozio Posted - 02/17/24

$PCVX so tight above the $$$ in 🧠⏰